Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pradier

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 14, 2021
[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak]M Durand, I Bentellis, F Barthe, et al.
AIDS (London, England)|March 9, 2000
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitorS Grabar, C Pradier, E Le Corfec, et al.
Presse Medicale (Paris, France : 1983)|February 20, 2002
[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]P M Roger, C Martin, M Taurel, et al.
HIV Medicine|July 14, 2005
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?I Perbost, B Malafronte, C Pradier, et al.
AIDS Care|June 13, 2013
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)E Rosenthal, L Piroth, E Cua, et al.
Scandinavian Journal of Gastroenterology|June 1, 2000
Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activityA Tran, F Longo, D Ouzan, et al.
The New England Journal of Medicine|February 24, 2001
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study GroupsB Ledergerber, A Mocroft, P Reiss, et al.
Transplantation Proceedings|December 19, 2006
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individualsG Busnach, P Piselli, E Arbustini, et al.
AIDS (London, England)|April 26, 2000
Cancer risk among men with, or at risk of, HIV infection in southern EuropeD Serraino, A Boschini, P Carrieri, et al.
HIV Medicine|July 23, 2013
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDAD Grint, L Peters, C Schwarze-Zander, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 14, 2021
[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak]M Durand, I Bentellis, F Barthe, et al.
AIDS (London, England)|March 9, 2000
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitorS Grabar, C Pradier, E Le Corfec, et al.
Presse Medicale (Paris, France : 1983)|February 20, 2002
[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]P M Roger, C Martin, M Taurel, et al.
HIV Medicine|July 14, 2005
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?I Perbost, B Malafronte, C Pradier, et al.
AIDS Care|June 13, 2013
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)E Rosenthal, L Piroth, E Cua, et al.
Scandinavian Journal of Gastroenterology|June 1, 2000
Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activityA Tran, F Longo, D Ouzan, et al.
The New England Journal of Medicine|February 24, 2001
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study GroupsB Ledergerber, A Mocroft, P Reiss, et al.
Transplantation Proceedings|December 19, 2006
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individualsG Busnach, P Piselli, E Arbustini, et al.
AIDS (London, England)|April 26, 2000
Cancer risk among men with, or at risk of, HIV infection in southern EuropeD Serraino, A Boschini, P Carrieri, et al.
HIV Medicine|July 23, 2013
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDAD Grint, L Peters, C Schwarze-Zander, et al.
Pageof 11